Opportunity at National Institute of Standards and Technology (NIST)
Novel Magnetic Imaging Biomarkers and Contrast Agents
Physical Measurement Laboratory, Applied Physics Division
Please note: This Agency only participates in the February and August reviews.
|Moreland, John Michael
The scope of MRI is expanding with the development of both ultrahigh field (14 T) and ultralow field (1 mT) scanners for biomedical applications. In addition, entirely new types of magnetic imaging modalities are being developed, including magnetic particle imaging (MPI), EPR-enhanced MRI, and optical detection of EPR in nanoparticles, to name a few examples. These advances will enable the development of new types of magnetic imaging agents that are useful not only for image enhancement but may have molecular and functional imaging capabilities, as well. We are interested in proposals that address their development as well as the development of the new instrumentation necessary for in-vivo imaging applications.
Bioimaging; Magnetic biomarkers; Magnetic contrast agents; Magnetic resonance imaging (MRI); Dynamic nuclear polarization (DNP); Electron paramagnetic resonance (EPR); Electron spin resonance (ESR); Magnetic particle imaging (MPI); Nitrogen vacancy centers in diamond; Bioendogenous magnetic biomarkers; Optical detection; Terahertz detection;
Open to U.S. citizens
Open to Postdoctoral applicants